Wells Fargo Reiterates Overweight on Boston Scientific, Maintains $62 Price Target

Boston Scientific Corporation -0.13%

Boston Scientific Corporation

BSX

67.33

-0.13%

Wells Fargo analyst Larry Biegelsen reiterates Boston Scientific (NYSE: BSX) with a Overweight and maintains $62 price target.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via